PhRMA named four members of its Guiding Principles independent review panel on DTC: Lawrence “L.B.” Brown, PhD, PharmD, University of Tennessee Department of Pharmaceutical Sciences; James Jones, MD, East Carolina University School of Medicine; Nancy Sharp, MSN, RN, FAAN, former head of the American College of Nurse Practitioners; and Lucille Perez, MD, 102nd president of the National Medical Association.